Dupont Capital Management Corp Sarepta Therapeutics, Inc. Transaction History

Dupont Capital Management Corp

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 25, 2023	BUY	$106.4 - $157.19 $87,354 - $129,052	821 Added 164.86%	1,319 $151,000
Q1 2023 Apr 28, 2023	SELL	$117.53 - $155.99 $358,113 - $475,301	-3,047 Reduced 85.95%	498 $68,000
Q4 2022 Jan 26, 2023	SELL	$100.86 - $132.13 $404,347 - $529,709	-4,009 Reduced 53.07%	3,545 $0
Q3 2022 Oct 31, 2022	BUY	$75.71 - $119.24 $235,760 - $371,313	3,114 Added 70.14%	7,554 $835,000
Q2 2022 Jul 26, 2022	BUY	$62.69 - $88.44 $278,343 - $392,673	4,440 New	4,440 $333,000
Q1 2020 Apr 29, 2020	SELL	$82.38 - $131.64 $343,442 - $548,807	-4,169 Closed	0 $0
Q3 2019 Oct 28, 2019	SELL	$72.81 - $156.91 $72,081 - $155,340	-990 Reduced 19.19%	4,169 $314,000
Q2 2019 Jul 30, 2019	SELL	$112.21 - $151.95 $233,621 - $316,359	-2,082 Reduced 28.75%	5,159 $784,000
Q1 2019 Apr 30, 2019	BUY	$106.67 - $151.68 $210,886 - $299,871	1,977 Added 37.56%	7,241 $863,000
Q3 2018 Nov 05, 2018	BUY	$115.31 - $161.51 $165,700 - $232,089	1,437 Added 37.55%	5,264 $850,000
Q2 2018 Jul 30, 2018	SELL	$71.74 - $153.69 $131,714 - $282,174	-1,836 Reduced 32.42%	3,827 $506,000
Q1 2018 May 02, 2018	SELL	$54.02 - $82.27 $848,438 - $1.29 Million	-15,706 Reduced 73.5%	5,663 $420,000
Q4 2017 Jan 31, 2018	BUY	$47.64 - $56.75 $411,943 - $490,717	8,647 Added 67.97%	21,369 $1.19 Million
Q3 2017 Oct 31, 2017	BUY	$35.73 - $47.15 $454,557 - $599,842	12,722	12,722 $577,000

529

84.2M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.4B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Dupont Capital Management Corp, based on Form 13F filings with the SEC.

Stay updated on Dupont Capital Management Corp with notifications on news.